https://www.selleckchem.com/pr....oducts/lurbinectedin
Finally, pathways analysis showed that these metabolites (such as lactate and pyruvate) were mainly enriched in pathways like disorders of the Krebs cycle. Combining with the transcriptomic and metabolomics data, we found that lactate, pyruvate, WASF3, RAB7B, and METTL7A might be used as novel biomarkers and potential therapeutic targets for BC. In addition, the disorders of the Krebs cycle pathway might affect the progression of BC. Combining with the transcriptomic and metabolomics data, we found that lactate, pyruvate, WASF3, R
Mi piace
Commento
Condividi
